We are live on ! Find out more
SGNT

SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT

Delisted

SGNT was delisted on the 29th of August, 2016.

Back to rankings

131 hedge funds and large institutions have $614M invested in SAGENT PHARMACEUTICALS INC COM STK (DE) in 2014 Q4 according to their latest regulatory filings, with 30 funds opening new positions, 57 increasing their positions, 30 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 10

90% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 30

15% more funds holding

Funds holding: 114 → 131 (+17)

16% less capital invested

Capital invested by funds: $734M → $614M (-$119M)

100% less call options, than puts

Call options by funds: $4K | Put options by funds: $1.26M

Holders
131
Holders Change
+17
Holders Change %
+14.91%
% of All Funds
3.49%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
57
Reduced
30
Closed
10
Calls
$4K
Puts
$1.26M
Net Calls
-$1.25M
Net Calls Change
-$1.25M

Top Buyers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$19.4M
2
RIM
Ranger Investment Management
Texas
+$7.44M
3
State Street
State Street
Massachusetts
+$5.56M
4
Millennium Management
Millennium Management
New York
+$4.87M
5
BFA
BlackRock Fund Advisors
California
+$4.78M

Top Sellers

Rank Fund Capital Flow
1
Franklin Resources
Franklin Resources
California
-$37.4M
2
TCM
Tekla Capital Management
Massachusetts
-$9.36M
3
PCM
Penn Capital Management
Pennsylvania
-$7.77M
4
SAM
Sectoral Asset Management
Quebec, Canada
-$5.74M
5
Fidelity Investments
Fidelity Investments
Massachusetts
-$4.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
26
Oxford Asset Management
United Kingdom
$3.43M +$1.92M +65,466 +93%
Geode Capital Management
27
Geode Capital Management
Massachusetts
$3.24M +$200K +6,815 +6%
TC
28
TFS Capital
Pennsylvania
$3.12M -$483K -16,451 -12%
Goldman Sachs
29
Goldman Sachs
New York
$3.06M +$3.35M +114,246 +1,506%
Citadel Advisors
30
Citadel Advisors
Florida
$2.94M +$3.43M +116,877 New
SIM
31
Spark Investment Management
New York
$2.83M +$1.05M +35,700 +46%
Invesco
32
Invesco
Georgia
$2.65M +$835K +28,473 +37%
JAM
33
JW Asset Management
Florida
$2.6M +$3.04M +103,483 New
American Century Companies
34
American Century Companies
Missouri
$2.58M +$3.01M +102,669 New
Ameriprise
35
Ameriprise
Minnesota
$2.52M +$43.8K +1,494 +2%
TCIM
36
TIAA CREF Investment Management
New York
$2.44M +$58.9K +2,009 +2%
First Trust Advisors
37
First Trust Advisors
Illinois
$2.2M +$2.37M +80,877 +1,226%
Deutsche Bank
38
Deutsche Bank
Germany
$2.19M +$298K +10,160 +13%
TCM
39
Tekla Capital Management
Massachusetts
$2.15M -$9.36M -319,231 -79%
BA
40
BlackRock Advisors
Delaware
$2.04M +$2.01M +68,452 +533%
Canada Life
41
Canada Life
Manitoba, Canada
$1.86M +$52.8K +1,800 +2%
BIM
42
BlackRock Investment Management
Delaware
$1.85M -$31.3K -1,068 -1%
GT
43
Glenmede Trust
Pennsylvania
$1.79M +$1.05M +35,664 +100%
Wellington Management Group
44
Wellington Management Group
Massachusetts
$1.75M +$2.05M +69,736 New
CCMH
45
Cornerstone Capital Management Holdings
New York
$1.7M +$182K +6,202 +10%
QI
46
QS Investors
New York
$1.65M +$1.93M +65,700 New
CS
47
Credit Suisse
Switzerland
$1.58M +$946K +32,257 +105%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$1.4M – – –
Prudential Financial
49
Prudential Financial
New Jersey
$1.4M -$893K -30,450 -35%
Asset Management One
50
Asset Management One
Japan
$1.38M +$1.21M +41,403 +301%
1
2
3 4 5

SGNT Hedge Fund Activity: Q4 2014 in Review

131 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) for Q4 2014, worth a combined $614M — down 16% from $734M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SGNT positions and 10 closed out — a net gain of 20 holders — while 57 added to existing stakes and 30 trimmed.

The largest buyer was Acadian Asset Management, adding an estimated $19.4M. The largest seller was Franklin Resources, cutting an estimated $37.4M.

  • 131 institutional investors held SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) as of Q4 2014, up from 114 in Q3 2014.
  • Funds reported $614M of SAGENT PHARMACEUTICALS INC COM STK (DE) stock for Q4 2014, down 16% quarter-over-quarter.
  • 30 funds opened new SAGENT PHARMACEUTICALS INC COM STK (DE) positions in Q4 2014 and 10 closed out, a net change of +20 holders.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) buyer in Q4 2014 was Acadian Asset Management, an estimated $19.4M added.
  • The largest SAGENT PHARMACEUTICALS INC COM STK (DE) seller in Q4 2014 was Franklin Resources, an estimated $37.4M sold.

Based on aggregated 13F filings for Q4 2014.